AM PHARMA
LIVE

Serial Number

79296424

Owner

AM-Pharma B.V.

Attorney

Krista Weber Powell

Filing Date

May 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AM PHARMA Trademark

Serial Number: 79296424 • Registration: 6688515

AM PHARMA is a trademark filed by AM-Pharma B.V. on May 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AM-Pharma B.V. (5 trademarks)

Stadsplateau 6
NL-3521 AZ Utrecht , NL

Entity Type: 16

Trademark Details

Filing Date

May 25, 2020

Registration Date

April 5, 2022

Published for Opposition

January 18, 2022

Goods & Services

Pharmaceutical and medical preparations for the treatment and prevention of infectious diseases, inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies; sanitary preparations for medical use; plasters for medical purposes, materials for medical and surgical dressings; disinfectants; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases, inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergies, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders

Services in the field of hygienic and beauty care for human beings

Scientific and technological services and research and design services related thereto, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely, scientific research, analysis, and reporting in the field of medicine; industrial analysis and industrial research in the field of medicine; development of technologies in the field of diagnostics, pharmaceuticals; biotechnological research related to enzymatic synthesis; testing of pharmaceuticals; quality control of goods and services; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research being pharmaceutical drug development services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; medical research and clinical research in the field of inflammatory diseases, kidney diseases, cancer, heart diseases, neurodegenerative diseases, deficiency diseases, autoimmune diseases, allergic diseases; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for pharmaceutical products of others

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 25, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 25, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 5, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 10, 2022 OPNX
REGISTERED-PRINCIPAL REGISTER
Apr 5, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 23, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 23, 2022 OPNR
NOTIFICATION PROCESSED BY IB
Jan 29, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 18, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 29, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 29, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 10, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 10, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 7, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 18, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 18, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 30, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 28, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 27, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 22, 2020 REPR